A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

Clinical trial NCT06308978 · RECRUITING

Trial details

NCT number: NCT06308978
Sponsor: Fate Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Systemic Sclerosis (SSc)Systemic Lupus Erythematosus (SLE)Lupus Nephritis

Start date: 2024-03-28
Primary completion: 2027-09-30
Enrollment: 244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.